Prenatal cystic fibrosis carrier screening: Factors in a woman's decision to decline testing
- 1 September 1993
- journal article
- clinical trial
- Published by Wiley in Prenatal Diagnosis
- Vol. 13 (9) , 807-814
- https://doi.org/10.1002/pd.1970130904
Abstract
Among 2207 women eligible to be screened for cystic fibrosis (CF) carrier status during pregnancy, 325 (15 per cent) declined to be tested. Of these, 260 (80 per cent) answered a questionnaire soliciting their reasons for not participating. The main factor was opposition to termination of pregnancy, with 43 per cent being against termination for any reason and another 11 per cent against termination of a CF fetus. Other reasons given were partner's disapproval or non‐participation (10 per cent), perceived risk of a CF child being low (7 per cent), the error rate of the test (6 per cent), and the generation of unacceptable levels of anxiety (5 per cent). Eleven women (4 per cent) said that they did not wish to be tested during pregnancy, but only six of these would have accepted screening at another time.Keywords
This publication has 10 references indexed in Scilit:
- Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.Journal of Medical Genetics, 1993
- Prenatal screening for cystic fibrosisThe Lancet, 1992
- Principles and practicalities of carrier screening: attitudes of recent parents.Journal of Medical Genetics, 1992
- Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.Journal of Medical Genetics, 1992
- Future use and development of prenatal diagnosis. Consumers' attitudesPrenatal Diagnosis, 1992
- Perceived risk not actual risk predicts uptake of amniocentesisBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Amniocentesis in the context of infertilityHealth Care for Women International, 1991
- Prenatal diagnosis for couples who would not consider abortionObstetrics & Gynecology, 1989
- Factors in a Woman??s Decision to Undergo Genetic Amniocentesis for Advanced Maternal AgeNursing Research, 1982